We are looking for talented postdocs with a passion for cancer biology. linkedin.com/jobs/view/3249…

instagram.com/p/Cq6mvF4sn7j/…

instagram.com/stories/uchica…

instagram.com/stories/_bk_50…

instagram.com/p/CtsPmpbJMFi/…

Brayden Kenny (2025 - IL) is excited to be a Golden Knight. He has decided on Clarkson. Brayden Kenny Clarkson Baseball #itscooltobesmart

instagram.com/p/DAY4vAvx9OT/…

Online now! Simultaneous publication with an #AACR25 poster: Navitoclax, a Bcl-2/xL inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth: doi.org/10.1158/1535-7… AACR

Pictured here are corresponding author Hilary A. Kenny, coauthor Tejas Samantaray, and our Assistant Editor Danielle Large, PhD. Congratulations to the authors. UChicago Obstetrics and Gynecology Department

Proud to share our latest work now in Cancer Cell. In collaboration with Max Planck Institute of Biochemistry (MPIB), we map the progression from borderline ovarian tumors to low-grade serous ovarian cancer & propose a promising new therapeutic strategy. sciencedirect.com/science/articl… #LGSC #SBT

Proud to share our new nature study: We developed the 1st NNMT inhibitor that reprograms cancer-associated fibroblasts, boosting immune response & stopping tumor growth in ovarian cancer models, especially when paired with immunotherapy. Lengyel Lab nature.com/articles/s4158…

We’re proud to share that our recent publication by Lisa Schweizer & Ernst Lengyel is featured on the cover of Cancer Cell! The artwork illustrates the malignant progression of borderline ovarian tumors to LGSOCs. Read the featured publication: bit.ly/4luXCP8

We’re proud to share that our lab’s recent publication by Lisa Schweizer & Ernst Lengyel was selected for the cover of Cancer Cell! The artwork illustrates the malignant progression of borderline ovarian tumors to LGSOCs. Read it here: cell.com/cancer-cell/fu…

I’m proud to share that our lab's latest work in collaboration with @MPI_biochem is featured on the cover of Cancer Cell. The artwork illustrates the malignant progression of borderline ovarian tumors to LGSOCs. Read the publication: cell.com/cancer-cell/fu…